Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Cell Therapeutics Says UW's Neuro-Oncology Program Begins Patient Enrolment

RELATED NEWS
Trade CTIC now with 

Cell Therapeutics, Inc. (CTIC: Quote) on Tuesday said the University of Washington's School of Medicine, Departments of Neurology and Neurosurgery, Division of Neuro-Oncology has begun enrolling patients in a randomized phase II clinical study comparing the combination of OPAXIO (paclitaxel poliglumex, PPX, CT-2103) and radiation therapy, or RT, to the combination of temozolomide, or TMZ, and RT for patients with newly-diagnosed glioblastoma multiforme.

The study objective is to determine whether paclitaxel poliglumex and RT are likely to improve progression-free survival and overall survival compared to TMZ and RT. It will also evaluate neuro-cognitive function and toxicities of these therapies.

Glioblastoma multiforme or GBM is a poor-prognosis high-grade malignant brain tumor with an active gene called MGMT, which substantially decreases the effectiveness of standard therapy with TMZ.

This study is a multicenter trial initiated and led by the Neuro-Oncology department of the Brown University Oncology Research Group in Providence, Rhode Island. The first patient at UW recently has been enrolled.

Click here to receive FREE breaking news email alerts for Cell Therapeutics Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
British economic growth remained high as expected in the second quarter as a robust expansion in the dominant service sector, and industry completely offset the slight weakness in the construction sector. With the second quarter expansion, GDP returned to its pre-crisis level. Gross domestic product grew 0.8 percent sequentially in the second quarter, the same rate as seen in the first quarter. 2.2 billion people in the world are poor or near-poor, according to the United Nations 2014 Human Development Report. Entitled Sustaining "Human Progress: Reducing Vulnerabilities and Building Resilience", the report was launched in Tokyo on Thursday by Japanese Prime Minister Shinzo Abe, United Nations... German business confidence eased for the third successive month to its lowest level since October, amid rising concerns over the impact of the worsening conflicts in Ukraine and the Middle East on the largest Eurozone economy. The Business Climate Index for industry and trade fell to 108.0 points in July from 109.7 in June, the results of a survey by the Munich-based Ifo Institute showed Friday.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.